QT/QTc Interval Prolongation
- E14/S7B Q&As: Questions & Answers - Clinical and Nonclinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential [2022-02-21]
- E14 Q&As (R3): Questions & Answers - The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs [2015-12-10]
- QT/QTc Interval Prolongation: Guidance for Product Monograph Content. This document was withdrawn as it is no longer reflective of current practices, science and/or policies [2010-03-31]
- Guide for the Analysis and Review of QT/QTc Interval Data [2010-03-31]
- Health Canada Question and Answer Document Regarding the ICH S7B and E14 Guidances [2006-11-30]
- S7B: The Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals [2006-04-05]
- E14: The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs [2006-04-05]
Page details
- Date modified: